4-Hydrazino-2-methylpyridine → N-Methyl-3-{3-[2-(2-methyl-pyridin-4-yl)-2H-pyrazol-3-yl]-4-oxo-4H-pyridazin-1-yl}-benzenesulfonamide
반응식
C[N:2](C)/[CH:3]=[CH:4]/[C:5]([C:7]1[C:12](=[O:13])[CH:11]=[CH:10][N:9]([C:14]2[CH:15]=[C:16]([S:20]([NH:23][CH3:24])(=[O:22])=[O:21])[CH:17]=[CH:18][CH:19]=2)[N:8]=1)=O.[NH:26]([C:28]1[CH:33]=[CH:32][N:31]=[C:30]([CH3:34])[CH:29]=1)N>>[CH3:24][NH:23][S:20]([C:16]1[CH:17]=[CH:18][CH:19]=[C:14]([N:9]2[CH:10]=[CH:11][C:12](=[O:13])[C:7]([C:5]3[N:26]([C:28]4[CH:33]=[CH:32][N:31]=[C:30]([CH3:34])[CH:29]=4)[N:2]=[CH:3][CH:4]=3)=[N:8]2)[CH:15]=1)(=[O:22])=[O:21]참가 물질
3
실험 절차
The product was obtained starting from 3-[3-((E)-3-Dimethylamino-acryloyl)-4-oxo-4H-pyridazin-1-yl]-N-methyl-benzenesulfonamide (A-31) and 4-hydrazino-2-methylpyridine according to the method described for example 91. MS: M=423.1 (M+H)+
후처리
- customThe product was obtained
출처 및 근거
- ORD 기록
- ord-60dc8d2c2f134827a5c62bc560006cbe